Future Prospects of the Benign Prostatic Hyperplasia Surgical Treatment Market : Growth Trends, Business Opportunities, Marketing Strategies, and Revenue Forecast (2025-2034)

Benign Prostatic Hyperplasia Surgical Treatment Market

According to Polaris Market Research analysis, the global benign prostatic hyperplasia surgical treatment market was valued at USD 12.62 billion in 2024. It is projected to reach USD 21.19 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2025-2034.

Market Overview

Benign prostatic hyperplasia is a condition in which the prostate expands in size. It surrounds the part of the urethra. The urethra is a tube that transports urine and sperm out of the body. As one becomes older, the amount of testosterone in the body reduces. Simultaneously, the estrogen levels stay the same. These hormonal alterations may cause prostate cells to evolve.

Several treatments are available for enlarged prostate. These involve surgery, medicines, and processes that include smaller, fewer, or no cuts. Medicines such as alpha blockers operate by moderating the smooth muscle of the bladder, neck, and prostate. Surgeries such as transurethral resection of the prostate (TURP) are performed in which a thin instrument is thrust into the urethra. It eases the symptoms swiftly.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/benign-prostatic-hyperplasia-surgical-treatment-market/request-for-sample

Market Growth Drivers

Growing Adaption of Minimally Invasive Surgeries: The growing adoption of minimally invasive surgeries is notably contributing to the market development. These procedures include laser therapy for BPH and transurethral microwave processes, which are being growingly preferred for speedier recuperation, decreased hospital stays, and least post-operative intricacies for enlarged prostate. This inclination is encouraging both patients and healthcare donors to select processes that convey enhanced clinical research, thereby propelling the benign prostatic hyperplasia surgical treatment market forward.

Rising Geriatric Population: The rising geriatric population is another critical factor leading to the increased market revenue. For instance, as per the World Health Organization (WHO) the quota of persons aged 60 and above is expected to surge from 12% to 22% of the worldwide population between 2015 to 2050. As the maturing population rises, so does the existence of prostate-connected issues such as BPH, generating notable demand for productive surgical solutions.

Competitive Insights

The market is excessively competitive with several pharmaceutical and medical devices firms providing a broad gamut of solutions from medicines to minimally invasive procedures. Key companies are mentioned below:

• Allium
• Alembic Pharmaceuticals Limited
• Asahi Kasei Corporation
• Asclepion Laser Technologies GmbH
• Boston Scientific Corporation
• Coloplast Group
• Cook Medical
• IPG Photonics Corporation
• Karl Storz Se & Co. KG
• Medifocus, Inc.
• Olympus Corporation
• PNN Medical A/S
• ProstaLund Ab
• PROCEPT BioRobotics Corporation
• Quanta System
• Richard Wolf GmbH
• SRS Medical
• Teleflex Incorporated
• Urologix, LLC

Inquire more about this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/benign-prostatic-hyperplasia-surgical-treatment-market/inquire-before-buying

Benign Prostatic Hyperplasia Surgical Treatment Market Report Highlights

o In terms of type, the laser surgeries segment accounted for a significant market share in 2024 due to their precision, minimal invasiveness, and shorter recovery time.
o Based on end user, the homecare settings segment accounted for the largest market share in 2024 due to growing patient preference for convenience and cost-effective treatment options.
o In 2024, North America accounted for the largest market share due to the high prevalence of BPH and advanced healthcare infrastructure.
o The Asia Pacific benign prostatic hyperplasia surgical treatment market is expected to witness the fastest growth during the forecast period due to increasing healthcare access and a rising elderly population.

Market Geography

The benign prostatic hyperplasia surgical treatment market provides a diverse geographical landscape, with several areas exhibiting unique market characteristics. North America held the largest share of the market in 2024 due to the elevated existence of BPH cases amidst the aging population.
Asia Pacific is projected to witness the fastest growth during the forecast period due to the growing consciousness of prostate health and enhancing healthcare reach in surfacing nations.

Benign prostatic hyperplasia surgical treatment Market, Regional Outlook
➽ North America
o Type Outlook
» Transurethral Resection of the Prostate (TURP)
» Laser Surgeries
» Urolift Procedures
» Rezum Procedures
» Robot-Assisted Waterjet Ablation
» Prostatic Stents
» Transurethral Microwave Thermotherapy (TUMT)
» Transurethral Needle Ablation of the Prostate (TUNA)
» Prostatic Arterial Embolization (PAE)
» Other Procedures
o End User Outlook
» Hospitals
» Ambulatory Surgery Centers and Clinics
» Homecare Settings

➽ Europe
o Type Outlook
» Transurethral Resection of the Prostate (TURP)
» Laser Surgeries
» Urolift Procedures
» Rezum Procedures
» Robot-Assisted Waterjet Ablation
» Prostatic Stents
» Transurethral Microwave Thermotherapy (TUMT)
» Transurethral Needle Ablation of the Prostate (TUNA)
» Prostatic Arterial Embolization (PAE)
» Other Procedures
o End User Outlook
» Hospitals
» Ambulatory Surgery Centers and Clinics
» Homecare Settings

Explore The Complete Report:
https://www.polarismarketresearch.com/industry-analysis/benign-prostatic-hyperplasia-surgical-treatment-market

Market Segmentation

Benign prostatic hyperplasia surgical treatment Market, Type Outlook (Revenue - USD Billion, 2020-2034)
• Transurethral Resection of the Prostate (TURP)
• Laser Surgeries
• Urolift Procedures
• Rezum Procedures
• Robot-Assisted Waterjet Ablation
• Prostatic Stents
• Transurethral Microwave Thermotherapy (TUMT)
• Transurethral Needle Ablation of the Prostate (TUNA)
• Prostatic Arterial Embolization (PAE)
• Other Procedures

Benign prostatic hyperplasia surgical treatment Market, End User Outlook (Revenue - USD Billion, 2020-2034)
• Hospitals
• Ambulatory Surgery Centers and Clinics
• Homecare Settings

More Trending Reports by Polaris Market Research:

E-Pharmacy Market:
https://www.polarismarketresearch.com/industry-analysis/e-pharma-market

Viscosupplementation Market:
https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market

Vertical Farming Market:
https://www.polarismarketresearch.com/industry-analysis/vertical-farming-market

Eyewear Market:
https://www.polarismarketresearch.com/industry-analysis/eyewear-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.